Literature DB >> 14081772

CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.

J LIEBERMAN.   

Abstract

Thrombolytic therapy holds great promise for becoming an important therapeutic adjunct in the treatment of acute vascular occlusions, but such therapy has not reached the stage for general clinical use. The optimum method of administering thrombolytic agents has not yet been determined, and the processes that bring about lysis of clots are incompletely understood. Current theories in this field are reviewed and the suggested modes of therapy and potential complications are discussed.

Entities:  

Keywords:  ANTICOAGULANTS; ASPERGILLUS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; FIBRINOLYSIN; FIBRINOLYSIS; PYROGENS; REVIEW; STREPTODORNASE AND STREPTOKINASE; THROMBOSIS

Mesh:

Substances:

Year:  1963        PMID: 14081772      PMCID: PMC1515298     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  14 in total

1.  Fibrinolytic mechanisms and the development of thrombolytic therapy.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  Am J Med       Date:  1962-11       Impact factor: 4.965

2.  Mechanism of thrombolysis.

Authors:  J RASMUSSEN
Journal:  Thromb Diath Haemorrh       Date:  1961

3.  Experimental studies: thrombolytic activity and related phenomena.

Authors:  N U BANG
Journal:  Thromb Diath Haemorrh       Date:  1961

4.  On the mechanism of thrombolysis by plasmin.

Authors:  C M AMBRUS; N BACK; J L AMBRUS
Journal:  Circ Res       Date:  1962-02       Impact factor: 17.367

5.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

6.  Factors affecting the formation and dissolution of experimental thrombi.

Authors:  A H FREIMAN; N U BANG; C E GROSSI; E E CLIFFTON
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

7.  The biochemistry and physiology of urokinase.

Authors:  D R CELANDER; M M GUEST
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

8.  Comparative effectiveness of intravenous and intra-arterial fibrinolysin therapy.

Authors:  P W BOYLES; W H MEYER; J GRAFF; C C ASHLEY; R G RIPIC
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

9.  Streptokinase as a thrombolytic agent.

Authors:  A J JOHNSON; W R McCARTY
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

10.  Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization.

Authors:  N BACH; J L AMBRUS; C L SIMPSON; S SHULMAN
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.